Skip to Main

Search

Results 1,751 to 1,760 of 10,000 for ""

UTSW builds AI-driven system to improve data collection : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-ai-model-speeds-medical-data-extraction.html

A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could dramatically reduce the time needed to create analysis-ready data for research studies.

Children’s Research Institute scientists uncover unique pathway tumors use to acquire antioxidant lipids: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-cri-utsw-pathway-tumors-antioxidant-lipids.html

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive stress, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Nature.

Artificial intelligence predicts kidney cancer therapy response: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/april-ai-kidney-cancer-therapy.html

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that’s only effective in some cases.

Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-kidney-cancer-drug.html

Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at UTSW, could offer hope to patients who develop this condition.

Study uncovers how biomolecular condensates cause some kidney cancers: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-biomolecular-kidney-cancers.html

A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center researchers suggests.

Clinical Trials: Clinical Research - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/research/clinical-research/domains/clinical-trials.html

As a crucial part of the clinical research process to develop new treatments, improve diagnosis, and help prevent diseases, UT Southwestern conducts clinical studies and clinical trials.

Sponsored Programs - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/research/spa/

Sponsored Programs Administration's purpose is to assist you throughout the entire award life cycle with reliability and efficiency.

FDA approval of belzutifan culminates 25-year journey at UTSW from gene discovery to a first-in-class drug: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/fda-approval-belzutifan.html

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

Clements University Hospital and UTSW clinics earn Press Ganey honors - CT Plus - UT Southwestern

https://www.utsouthwestern.edu/ctplus/honors-awards/press-ganey.html

William P. Clements Jr. University Hospital and UTSW clinics have been recognized for excellence in patient satisfaction by Press Ganey, a national consulting firm specializing in health care performance.

Camp, dela Cruz receive Faculty Innovation in Education Awards - CT Plus - UT Southwestern

https://www.utsouthwestern.edu/ctplus/honors-awards/camp-delacruz.html

Associate Professor of Psychiatry Dr. Molly Camp and Assistant Professor of Psychiatry Dr. Adriane dela Cruz recently received Faculty Innovation in Education Awards from the American Board of Psychiatry and Neurology Inc.